Metropolitan Life Insurance CO Cel Sci Corp Transaction History

Metropolitan Life Insurance CO

$2.27 Billion
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$3.93 - $7.7 $19,363 - $37,937	-4,927 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$7.1 - $12.82 $34,981 - $63,164	4,927 New	4,927 $34,000
Q4 2021 Mar 30, 2023	SELL	$7.1 - $12.82 $11,523 - $20,806	-1,623 Reduced 24.78%	4,927 $34,000
Q4 2021 Feb 15, 2022	SELL	$7.1 - $12.82 $11,523 - $20,806	-1,623 Reduced 24.78%	4,927 $35,000
Q3 2021 Jun 21, 2023	BUY	$7.64 - $12.49 $50,042 - $81,809	6,550 New	6,550 $71,000

Q3 2021 Mar 30, 2023	SELL	$7.64 - $12.49 $32,431 - $53,020	-4,245 Reduced 39.32%	6,550 $71,000
Q3 2021 Nov 15, 2021	SELL	$7.64 - $12.49 $32,431 - $53,020	-4,245 Reduced 39.32%	6,550 $72,000
Q2 2021 Jun 21, 2023	BUY	$8.68 - $27.49 $93,700 - $296,754	10,795 New	10,795 $93,000
Q2 2021 Mar 30, 2023	BUY	$8.68 - $27.49 $11,422 - $36,176	1,316 Added 13.88%	10,795 $93,000
Q2 2021 Aug 16, 2021	BUY	$8.68 - $27.49 $93,622 - $296,507	10,786 Added 119844.44%	10,795 $94,000
Q1 2021 Jun 26, 2023	BUY	$12.0 - $27.64 $113,748 - $261,999	9,479 New	9,479 $144 Million
Q1 2021 Mar 30, 2023	SELL	$12.0 - $27.64 $12,636 - $29,104	-1,053 Reduced 10.0%	9,479 $144,000
Q1 2021 May 14, 2021	SELL	$12.0 - $27.64 $126,276 - $290,855	-10,523 Reduced 99.91%	9 $144,000
Q4 2020 Jun 22, 2023	BUY	$11.05 - $16.62 $116,378 - $175,041	10,532 New	10,532 $122,000
Q3 2020 Jun 26, 2023	BUY	$11.69 - $14.54 $123,119 - $153,135	10,532 New	10,532 $134,000
Q2 2020 Jun 26, 2023	BUY	$9.75 - $17.6 $102,687 - $185,363	10,532 New	10,532 $157,000
Q1 2020 Jul 12, 2023	BUY	$7.54 - $17.05 $79,411 - $179,570	10,532 New	10,532 $121,000
Q1 2020 Mar 30, 2023	BUY	$7.54 - $17.05 $11,634 - $26,308	1,543 Added 17.17%	10,532 $121,000
Q1 2020 May 15, 2020	BUY	$7.54 - $17.05 $11,634 - $26,308	1,543 Added 17.17%	10,532 $122,000
Q4 2019 Jul 12, 2023	BUY	$6.71 - $9.55 $60,316 - $85,844	8,989 New	8,989 $82,000
Q4 2019 Mar 30, 2023	SELL	$6.71 - $9.55 $10,762 - $15,318	-1,604 Reduced 15.14%	8,989 $82,000
Q4 2019 Feb 14, 2020	SELL	$6.71 - $9.55 $10,762 - $15,318	-1,604 Reduced 15.14%	8,989 $82,000
Q3 2019 Jul 12, 2023	BUY	$6.0 - $9.6 $63,558 - $101,692	10,593 New	10,593 $94,000
Q3 2019 Mar 30, 2023	BUY	$6.0 - $9.6 $63,558 - $101,692	10,593 New	10,593 $94,000
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $63,558 - $101,692	10,593 New	10,593 $95,000

Others Institutions Holding CVM

# of Institutions

Shares Held

7.5M

Call Options Held

61.8K

Put Options Held

141K

Vanguard Group Inc Valley Forge, PA

2.19M
Shares

$2.39 Million
0.0% of portfolio
Cvi Holdings, LLC Wilmington, DE

879K
Shares

$957,856
12.54% of portfolio
Black Rock Inc. New York, NY

763K
Shares

$832,152
0.0% of portfolio
Susquehanna International Group, LLP Bala Cynwyd, PA

669K
Shares

$729,198
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

464K
Shares

$506,205
0.0% of portfolio

View Full List

About CEL SCI CORP

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $47.3M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

More about CVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account